Sangamo Therapeutics Inc (SGMO)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -38.205 | -24.545 | -15.581 | -15.504 | -15.354 | -21.474 | -29.94 | -70.849 |
| Return on Equity (%) | -43.61 | -33.674 | -24.618 | -23.797 | -26.018 | -40.858 | -57.371 | -136.474 |
| Return on Invested Capital (%) | -43.668 | -32.493 | -23.653 | -26.694 | -31.073 | -52.464 | -78.184 | -78.018 |
| Operating Margin (%) | -369.653 | -149.227 | -81.572 | -93.157 | -102.187 | -160.785 | -172.373 | -149.18 |
| Net Profit Margin (%) | -369.581 | -149.227 | -80.915 | -92.93 | -102.372 | -161.052 | -172.758 | -146.302 |
| Book Value Per Share | 1.899 | 2.177 | 2.665 | 2.934 | 2.791 | 1.932 | 1.239 | 0.467 |
| Earnings Per Share | -1.011 | -0.637 | -0.669 | -0.821 | -0.852 | -1.222 | -1.153 | -1.454 |
| Cash Per Share | 0.311 | 0.582 | 1.374 | 0.694 | 0.924 | 1.226 | 0.602 | 0.255 |
| Working Capital Per Share | 1.923 | 2.378 | 3.249 | 2.894 | 3.633 | 1.856 | 1.131 | 0.263 |
| Operating Profit Per Share | 0.274 | 0.427 | 0.826 | 0.883 | 0.832 | 0.759 | 0.667 | 0.994 |
| EBIT Per Share | -1.011 | -0.637 | -0.674 | -0.823 | -0.85 | -1.22 | -1.15 | -1.482 |
| EBITDA Per Share | -1.011 | -0.637 | -0.674 | -0.823 | -0.85 | -1.22 | -1.15 | -1.482 |
| Free Cash Flow Per Share | -1.015 | -0.611 | -0.27 | -0.676 | -0.788 | -1.127 | -1.104 | -1.419 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 70.87M | 85.6M | 102.19M | 115.97M | 142.06M | 145.92M | 166.79M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 156.55M | 163.88M | 166.79M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | 13.502 | N/A | N/A | N/A | -10185.239 |
| Net Profit Margin (%) | N/A | N/A | N/A | 13.379 | N/A | N/A | N/A | -10205.613 |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 171.91M |
| Price to Earnings Ratio | -0.68 |
| Price to Sales Ratio | 0.99 |
| Price to Cash Ratio | 3.87 |
| Price to Book Ratio | 2.11 |
| Dividend Yield | - |
| Shares Outstanding | 208.22M |
| Average Volume (1 week) | 1.71M |
| Average Volume (1 Month) | 2.4M |
| 52 Week Change | 50.35% |
| 52 Week High | 1.48 |
| 52 Week Low | 0.2911 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
